A detailed history of Squarepoint Ops LLC transactions in Personalis, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 17,020 shares of PSNL stock, worth $103,651. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,020
Holding current value
$103,651
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.19 - $6.34 $20,253 - $107,906
17,020 New
17,020 $91,000
Q1 2024

May 15, 2024

BUY
$1.15 - $2.19 $42,945 - $81,783
37,344 Added 84.49%
81,542 $121,000
Q4 2023

Feb 14, 2024

BUY
$0.93 - $2.35 $41,104 - $103,865
44,198 New
44,198 $92,000
Q2 2022

Aug 15, 2022

SELL
$3.27 - $8.76 $23,871 - $63,948
-7,300 Reduced 13.71%
45,941 $158,000
Q1 2022

May 16, 2022

BUY
$7.56 - $14.3 $402,501 - $761,346
53,241 New
53,241 $436,000
Q3 2021

Nov 15, 2021

SELL
$16.69 - $26.05 $157,453 - $245,755
-9,434 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$18.15 - $27.75 $171,227 - $261,793
9,434 New
9,434 $239,000
Q4 2020

Feb 16, 2021

SELL
$21.84 - $44.0 $730,744 - $1.47 Million
-33,459 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$13.63 - $24.12 $456,046 - $807,031
33,459 New
33,459 $725,000
Q2 2020

Aug 14, 2020

SELL
$7.65 - $14.11 $714,938 - $1.32 Million
-93,456 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$4.75 - $12.41 $416,822 - $1.09 Million
-87,752 Reduced 48.43%
93,456 $754,000
Q4 2019

Feb 14, 2020

BUY
$8.73 - $12.95 $1.2 Million - $1.78 Million
137,433 Added 313.95%
181,208 $1.98 Million
Q3 2019

Nov 14, 2019

BUY
$14.16 - $25.34 $619,854 - $1.11 Million
43,775 New
43,775 $642,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $280M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.